David Dvorak Insider Profile
4 Followers
David Dvorak, President & CEO, Director at Zimmer Biomet Holdings, holds 294.56K shares in Zimmer Biomet Holdings (Ticker: ZBH), holds 1.92K shares in St Jude Medical (Ticker: STJ).
David Dvorak's Trading History
| ZBHZimmer Biomet Holdings | May 01, 2017 | President & CEO, Director | Uninformative Buy | 1.12M | $30.40M | |
| STJSt Jude Medical | Jan 06, 2017 | ― | Uninformative Sell | ― | $155.26K |
You May Also Like
David Dvorak insider profile FAQ
What is the percentage of profitable transactions made by David Dvorak?
The percentage of profitable transactions made by David Dvorak is 50%.
What is the average return per transaction made by David Dvorak?
The average return per transaction made by David Dvorak is -10.00%.
What stocks does David Dvorak hold?
David Dvorak holds: ZBH, STJ stocks.
What was David Dvorak’s latest transaction?
David Dvorak’s latest transaction was an Uninformative Buy of $1.12M.
What was David Dvorak's most profitable transaction?
David Dvorak’s most profitable transaction was an Informative Sell of ZBH stock on May 3, 2011. The return on the trade was 2.90%.
What is David Dvorak's role in Zimmer Biomet Holdings?
David Dvorak's role in Zimmer Biomet Holdings is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
